(Q28217688)

title

The antidepressant and antiinflammatory effects of rolipram in the central nervous system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741679&resulttype=core&format=json

12 May 2020

0 references

3

B Winblad

0 references

author name string

J Zhu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741679&resulttype=core&format=json

12 May 2020

E Mix

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741679&resulttype=core&format=json

12 May 2020

B Winblad

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741679&resulttype=core&format=json

CNS Neuroscience & Therapeutics

12 May 2020

language of work or name

English

0 references

publication date

2001

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741679&resulttype=core&format=json

12 May 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741679&resulttype=core&format=json

12 May 2020

page(s)

387-398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741679&resulttype=core&format=json

12 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741679&resulttype=core&format=json

12 May 2020

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2001.TB00206.X

Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2001.TB00206.X

Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2001.TB00206.X

Effects of nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors on antigen-induced cytokine gene expression in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2001.TB00206.X

Neurotransmitters in Anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2001.TB00206.X

The acute toxic effect of the phosphodiesterase inhibitor rolipram on plasma osmolality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2001.TB00206.X

Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2001.TB00206.X

Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase

21 January 2018

1 reference

12 December 2020

Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors.

1 reference

12 December 2020

Lymphocyte suppression by rolipram with other immunosuppressive drugs

1 reference

12 December 2020

Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus

1 reference

12 December 2020

Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats

1 reference

12 December 2020

Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells

1 reference

12 December 2020

Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice

1 reference

12 December 2020

Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram

1 reference

12 December 2020

CGS 21680, dibutyryl cyclic AMP and rolipram attenuate the pro-inflammatory interactions of the Pseudomonas aeruginosa -derived pigment, 1-hydroxyphenazine, with human neutrophils

1 reference

12 December 2020

Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system

1 reference

12 December 2020

Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication

1 reference

12 December 2020

PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway

1 reference

12 December 2020

"cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.

1 reference

12 December 2020

The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat.

1 reference

12 December 2020

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo

1 reference

12 December 2020

Inflammation contributes to the postponed ischemic neuronal damage following treatment with a glutamate antagonist in rats

1 reference

12 December 2020

A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice

1 reference

12 December 2020

Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain

1 reference

12 December 2020

Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists

1 reference

12 December 2020

Inhibiting the inflammatory response in joint sepsis

1 reference

12 December 2020

Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis

1 reference

12 December 2020

Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro.

1 reference

12 December 2020

Syntheses and evaluation of pyrido[2,3-dlpyrimidine-2,4-diones as PDE 4 inhibitors

1 reference

12 December 2020

Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide

1 reference

12 December 2020

EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID

1 reference

12 December 2020

New pharmacological approaches to the management of depression: from theory to clinical practice

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function

1 reference

12 December 2020

Tumor necrosis factor-alpha is chemokinetic for lymphokine-activated killer cells: regulation by cyclic adenosine monophosphate.

1 reference

12 December 2020

Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected

1 reference

12 December 2020

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma

1 reference

12 December 2020

4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain

1 reference

12 December 2020

In-patient major depression: is rolipram as effective as amitriptyline?

1 reference

12 December 2020

cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells

1 reference

12 December 2020

Antidepressant effects of rolipram in a genetic animal model of depression: cholinergic supersensitivity and weight gain

1 reference

12 December 2020

Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine

1 reference

12 December 2020

Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.

1 reference

12 December 2020

Excitation of area postrema neurons by transmitters, peptides, and cyclic nucleotides.

1 reference

12 December 2020

Rolipram, a stereospecific inhibitor of calmodulin-independent phosphodiesterase, causes beta-adrenoceptor subsensitivity in rat cerebral cortex.

1 reference

12 December 2020

Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine in hospitalized major and/or endogenous depressives

1 reference

12 December 2020

Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach

1 reference

12 December 2020

Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences

1 reference

12 December 2020

Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3?,5?-monophosphate phosphodiesterase inhibitors

1 reference

12 December 2020

Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors

1 reference

12 December 2020

Results of a phase II study of the antidepressant effect of rolipram

1 reference

12 December 2020

The influence of rolipram on the central serotoninergic system

1 reference

12 December 2020

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

1 reference

12 December 2020

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

12 December 2020

Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys.

1 reference

12 December 2020

Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site

1 reference

12 December 2020

Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats.

1 reference

12 December 2020

Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor

1 reference

12 December 2020

Modulation of antigen- and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors

1 reference

12 December 2020

Expression and regulation of human and rat phosphodiesterase type IV isogenes

1 reference

12 December 2020

Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition

1 reference

12 December 2020

High-affinity cAMP phosphodiesterase and adenosine localized in sensory organs

1 reference

12 December 2020

Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats

1 reference

12 December 2020

Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.

1 reference

12 December 2020

Emetic, central nervous system, and pulmonary activities of rolipram in the dog.

1 reference

12 December 2020

Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis

1 reference

12 December 2020

Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B

1 reference

12 December 2020

cAMP-dependent protein kinase activity in major depression

1 reference

12 December 2020

The toxicity of repeated exposures to rolipram, a type IV phosphodiesterase inhibitor, in rats

1 reference

12 December 2020

Rapid regulation of a cyclic AMP-specific phosphodiesterase (PDE IV) by forskolin and isoproterenol in LRM55 astroglial cells

1 reference

12 December 2020

Neurotransmitters, signal transduction and second-messengers in Alzheimer's disease

1 reference

12 December 2020

The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-beta 1b treatment in patients with multiple sclerosis

1 reference

12 December 2020

Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats

1 reference

12 December 2020

A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosis.

1 reference

12 December 2020

Suppression of experimental autoimmune neuritis by phosphodiesterase inhibitor pentoxifylline.

1 reference

12 December 2020

Regulation of interleukin-13 by type 4 cyclic nucleotide phosphodiesterase (PDE) inhibitors in allergen-specific human T lymphocyte clones

1 reference

12 December 2020

Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells

1 reference

12 December 2020

Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease

1 reference

12 December 2020

Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation

1 reference

12 December 2020

Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline.

1 reference

12 December 2020

The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.

1 reference

12 December 2020

Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline

1 reference

12 December 2020

10.1111/J.1527-3458.2001.TB00206.X

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

4308694

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741679&resulttype=core&format=json

12 May 2020

4308694

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741679&resulttype=core&format=json

12 May 2020

2 references

Consolidated OpenCitations Corpus – April 2017

4308694